JANX FY 2021 Earnings — Janux Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

JANXJanux Therapeutics, Inc.

$852M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M

Gross Profit

$4M100.0% margin

Operating Income

-$33M-905.4% margin

Net Income

-$33M-898.3% margin

EPS (Diluted)

$-0.79

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$18M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$380M

Total Liabilities

$13M

Stockholders' Equity

$366M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$0	—
Gross Profit	$4M	-$13,000	+28076.9%
Operating Income	-$33M	-$5M	-579.9%
Net Income	-$33M	-$7M	-381.6%